Ziftomenib Maintenance Post Allo-HCT

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ziftomenib Maintenance Post Allo-HCT	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 1	2026-10-06		NCT06440135

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Massachusetts General Hospital	758

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Massachusetts General Hospital	Boston	United States	1015
Ohio State University Wexner Medical Center- James Cancer Hospital	Columbus	United States	2

Clinical trials